A tissue freezing solution for single-cell sequencing and its preparation method and application

By using combinations of sodium chloride, sodium bicarbonate and other components in tissue frozen liquid, the problem of low cell viability and nucleation rate is solved, and the freezing effect of maintaining high cell activity under low temperature conditions is achieved. It is suitable for Single-cell sequencing.

CN118633593BActive Publication Date: 2024-11-05BEIJING BAIAO YIKANG PHARM TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411087675.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-09
Publication Date
2024-11-05
Estimated Expiration
2044-08-09

AI Technical Summary

Technical Problem

During the sample storage process, existing tissue frozen stocks often have problems such as decreased cell viability, decreased total number of live cells, high cell clot rate and/or low nucleation rate, which is difficult to meet the needs of single-cell sequencing.

Method used

Provided is a type of glutamate including sodium chloride, sodium bicarbonate, potassium chloride, magnesium chloride hexahydrate, fetal bovine serum, dimethyl sulfoxide, lactonic acid, hydroxyethyl starch, adenosine, hemoglobin, mannitol, reduced glutamate The tissue frozen solution of glycone, palmitoyl carnitine, carotenoid and ergothionein can maintain the energy metabolism balance, antioxidant capacity and membrane stability of cells through the synergistic effect of these components, and improve cell viability and nucleation. Rate.

Benefits of technology

Effectively maintain cell activity, reduce cell loss during preservation, improve cell viability and nucleation rate, improve sample quality and experimental reliability of single-cell sequencing. It is suitable for ex vivo tissues of humans, mice and other mammals.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118633593B_ABST
    Figure CN118633593B_ABST
Patent Text Reader

Abstract

The present invention relates to a tissue cryopreservation solution for single-cell sequencing and a preparation method and application thereof, belonging to the technical field of tissue cryopreservation solution. The raw materials for preparing the tissue cryopreservation solution for single-cell sequencing include sodium chloride, sodium bicarbonate, potassium chloride, magnesium chloride hexahydrate, calcium chloride dihydrate, fetal bovine serum, dimethyl sulfoxide, lactobionic acid, hydroxyethyl starch, adenosine, hemoglobin, mannitol, reduced glutathione, palmitoyl carnitine, carotenoids, ergothioneine and deionized water. The tissue cryopreservation solution for single-cell sequencing provided by the present invention can effectively maintain cell activity, reduce cell loss during storage, improve cell viability, reduce cell agglomeration rate, and is conducive to improving the nucleation rate, thereby being conducive to improving the sample quality and experimental reliability of single-cell sequencing.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of tissue cryopreservation fluid, and in particular relates to a tissue cryopreservation fluid for single-cell sequencing, and a preparation method and application thereof. Background Art

[0002] High-throughput sequencing can sequence hundreds of thousands to millions of DNA molecules in parallel at one time, with the advantages of high throughput, fast detection speed, flexibility and versatility, and low cost. High-throughput single-cell sequencing technology can accurately analyze the composition information of sample cells, and combined with high-throughput sequencing methods, it can reveal the gene structure and gene expression status of individual cells on a large scale, and reflect the heterogeneity between cells.

[0003] In single-cell experiments, fresh samples are usually the first choice. However, for some reasons, some samples cannot be digested in time, and tissue cryopreservation fluid can be used for preservation. In the process of single-cell sequencing, the preparation and preservation of early samples often face the challenges of difficult sample preservation, short storage time, and inability to collect samples for experiments at the same time. Compared with the timeliness of fresh samples, frozen tissues are more suitable for long-distance transportation, especially for samples that need to be collected in batches over a period of time, or precious samples that are difficult to collect. In order to maintain cell activity, fresh tissues used for single-cell dissociation can be frozen by soaking in tissue cryopreservation fluid. However, existing tissue cryopreservation fluids often have problems such as reduced cell viability, reduced total number of live cells, high cell clumping rate and / or low nucleation rate during sample preservation.

[0004] Therefore, it is very necessary to develop an improved tissue freezing fluid and its preparation method and application to better meet the needs of single-cell sequencing. Summary of the invention

[0005] In order to solve one or more technical problems existing in the prior art, the present invention provides a tissue freezing solution for single-cell sequencing and a preparation method and application thereof.

[0006] In a first aspect, the present invention provides a tissue freezing solution for single-cell sequencing. The raw materials for preparing the tissue freezing solution for single-cell sequencing include sodium chloride, sodium bicarbonate, potassium chloride, magnesium chloride hexahydrate, calcium chloride dihydrate, fetal bovine serum, dimethyl sulfoxide, lactobionic acid, hydroxyethyl starch, adenosine, hemoglobin, mannitol, reduced glutathione, palmitoylcarnitine, carotenoids, ergothioneine and deionized water.

[0007] Preferably, the raw materials for preparing the tissue freezing solution for single-cell sequencing include the following components per 1000 parts of raw materials, in parts by weight: 3 to 5 parts of sodium chloride, 0.5 to 1.5 parts of sodium bicarbonate, 0.1 to 0.2 parts of potassium chloride, 0.1 to 0.2 parts of magnesium chloride hexahydrate, 0.1 to 0.2 parts of calcium chloride dihydrate, 500 to 700 parts of fetal bovine serum, 50 to 150 parts of dimethyl sulfoxide, 30 to 50 parts of lactobionic acid, 30 to 60 parts of hydroxyethyl starch, 0.5 to 2 parts of adenosine, 1.8 to 4.2 parts of hemoglobin, 12 to 15 parts of mannitol, 1.2 to 1.8 parts of reduced glutathione, 3 to 10 parts of palmitoyl carnitine, 0.5 to 2 parts of carotenoids, 1 to 5 parts of ergothioneine, and the balance deionized water.

[0008] Preferably, the mass ratio of the palmitoylcarnitine, the carotenoid and the ergothioneine is (4-6):1:(1.8-2.5); and / or the carotenoid is one or more of β-carotene, astaxanthin and lycopene.

[0009] Preferably, the pH value of the tissue freezing solution used for single-cell sequencing is 7.3-7.6.

[0010] Preferably, the pH value of the tissue freezing solution for single-cell sequencing is adjusted to 7.3-7.6 using hydrochloric acid solution and / or sodium hydroxide solution.

[0011] In a second aspect, the present invention provides a method for preparing a tissue cryopreservation solution for single-cell sequencing according to the first aspect of the present invention, the method comprising the following steps:

[0012] (1) Weighing each raw material and mixing and stirring to uniformly disperse it to obtain a freezing solution system;

[0013] (2) The cryopreservation solution system is sterilized by filtering to prepare tissue cryopreservation solution for single-cell sequencing.

[0014] Preferably, before the freezing solution system is filtered and sterilized, the pH of the freezing solution system is adjusted to 7.3-7.6.

[0015] Preferably, the filter is a filter with a pore size of 0.22 μm; and / or the tissue cryopreservation solution for single-cell sequencing is stored at -20°C.

[0016] The third aspect of the present invention provides use of the tissue freezing solution for single-cell sequencing described in the first aspect of the present invention in single-cell sequencing.

[0017] Preferably, the application is: first cryopreserving the tissue using the tissue cryopreservation solution for single-cell sequencing, then thawing the frozen tissue and digesting the tissue into a single-cell suspension, and finally performing single-cell sequencing using the single-cell suspension.

[0018] Compared with the prior art, the present invention has at least the following beneficial effects:

[0019] (1) The tissue cryopreservation solution provided by the present invention has simple components, is easy to prepare, has easily available raw materials, and has a long shelf life; the tissue cryopreservation solution provided by the present invention has a wide range of applications, and is applicable to ex vivo tissues from humans, mice, and other mammals; the components of the tissue cryopreservation solution provided by the present invention have no toxic effects on cells or tissues, do not affect the physiological functions of preserved cells or tissues, can maintain high cell activity of human and animal tissues under low temperature conditions (-20°C), and are more convenient for ex vivo tissue cryopreservation and transportation; ex vivo tissues preserved with the tissue cryopreservation solution provided by the present invention can be digested and dissociated to prepare high-quality single-cell suspensions, which can be well used in related experiments of high-throughput single-cell sequencing.

[0020] (2) The tissue cryopreservation solution provided by the present invention contains dimethyl sulfoxide, which is a cryoprotectant and also a permeability protectant. It can quickly penetrate the cell membrane and enter the cell, lower the freezing point of the cell, delay the cryopreservation process, reduce the formation of ice crystals, and reduce the damage of free radicals to the cell, thereby reducing cell damage. The tissue cryopreservation solution provided by the present invention contains lactobionic acid, hydroxyethyl starch and adenosine. These ingredients can provide energy and maintain the minimum physiological metabolic conditions of tissue cells. At the same time, hydroxyethyl starch and lactobionic acid can also be used as osmotic stabilizers to avoid cell membrane rupture caused by temperature changes under storage conditions or solution osmotic differences; the tissue cryopreservation solution provided by the present invention contains hemoglobin, which can improve the stability and cryopreservation effect of the tissue cryopreservation solution; the tissue cryopreservation solution provided by the present invention contains hemoglobin, which can improve the stability and cryopreservation effect of the tissue cryopreservation solution; The tissue freezing solution contains reduced glutathione, which can remove free radicals generated during tissue cell metabolism, maintain the redox environment in the cells, prevent cell apoptosis during storage, and prevent the resulting intracellular nucleic acid degradation; the tissue freezing solution provided by the present invention contains mannitol. The present invention finds that mannitol can not only reduce cell membrane rupture caused by osmotic pressure changes during freezing and thawing by regulating the osmotic pressure inside and outside the cells, but also remove free radicals generated during cell metabolism, reduce the damage of oxidative stress to cells, and help protect cell membranes and biological molecules in cells. In addition, mannitol can protect the structure and function of cells, especially under low-temperature storage conditions, it helps to stabilize cell membranes and organelles, thereby facilitating improving cell survival rate.

[0021] (3) The present invention has found that when the tissue cryopreservation solution contains dimethyl sulfoxide, lactobionic acid, hydroxyethyl starch, adenosine, hemoglobin, mannitol and reduced glutathione at the same time, it has a good effect on enhancing the performance of the tissue cryopreservation solution in maintaining cell viability, reducing cell agglomeration rate and improving nucleation rate, in particular, the tissue cryopreservation solution provided by the present invention also contains palmitoyl carnitine, carotenoids and ergothioneine. This is the first time that these three components are used in combination in a tissue cryopreservation solution. The present invention has found that the combined use of palmitoyl carnitine, carotenoids and ergothioneine can further significantly enhance the performance of the tissue cryopreservation solution in maintaining cell viability, reducing cell agglomeration rate and improving nucleation rate; this may be because the synergistic effect of these three components in the tissue cryopreservation solution, through multiple mechanisms, jointly maintains the energy metabolism balance, antioxidant capacity and membrane stability of the cells, thereby significantly improving cell viability, reducing cell agglomeration rate and improving nucleation rate. Specifically, the possible reason is that palmitoylcarnitine can promote the β-oxidation of fatty acids in mitochondria during the thawing process, help restore and maintain the energy supply of cells, support the function and repair ability of the nucleus, and ensure that more cells retain intact nuclei after thawing, which helps to improve cell viability, reduce cell agglomeration rate and increase the nucleus rate, which is crucial for cell cryopreservation; at the same time, palmitoylcarnitine has good antioxidant properties, which can reduce the damage of oxidative stress to cells, while carotenoids and ergothioneine can also indirectly support cell energy by reducing oxidative stress and protecting mitochondrial function. Metabolism, they jointly provide powerful antioxidant protection, reduce the accumulation of reactive oxygen species during freezing, protect cell membranes and organelles, thereby helping to maintain cell activity, protect the cell nucleus from damage, prevent cell apoptosis and nucleic acid degradation, reduce cell agglomeration rate and increase nucleation rate; in addition, palmitoylcarnitine and carotenoids work together to improve the fluidity and stability of cell membranes, reduce membrane rupture and cell-to-cell adhesion, help stabilize cell membranes, and reduce ice crystal damage to cells. At the same time, ergothioneine helps to reduce oxidative damage to cell membranes, reduce oxidative cross-linking of membrane proteins, and help reduce cell agglomeration rate.

[0022] (4) The new tissue cryopreservation solution provided by the present invention can effectively maintain cell activity, reduce cell loss during storage, improve cell viability, reduce cell clumping rate, and help improve the nucleation rate, thereby helping to improve the sample quality and experimental reliability of single-cell sequencing; the tissue cryopreservation solution for single-cell sequencing in the present invention can take into account the activity and function of multiple cell types, and is used to maintain the activity of different types of cells in the tissue, and can ensure that as many living cells as possible are obtained in the subsequent single-cell digestion and dissociation process. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 is a flow chart of preparing tissue cryopreservation solution for single-cell sequencing in some specific embodiments of the present invention;

[0024] Figure 2 It is a fluorescence image of live cells in a mouse spleen tissue single cell suspension when the tissue cryopreservation solutions in Example 1 and Comparative Example 6 of the present invention are used for cryopreservation of mouse spleen tissue; in the figure, (a) is the result of the tissue cryopreservation solution of Comparative Example 6, and (b) is the result of the tissue cryopreservation solution of Example 1;

[0025] Figure 3 It is a fluorescence image of live cells in a single cell suspension of colorectal cancer tissue when the tissue cryopreservation solution in Example 1 of the present invention is used for cryopreservation of human clinical tissue;

[0026] Figure 4 This is a fluorescence image of live cells in a single cell suspension of liver cancer tissue when the tissue cryopreservation solution in Example 1 of the present invention is used for human clinical tissue cryopreservation. DETAILED DESCRIPTION

[0027] In order to make the purpose, technical solution and advantages of the present invention clearer, the technical solution of the present invention will be clearly and completely described below in combination with the embodiments of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.

[0028] In a first aspect, the present invention provides a tissue freezing solution for single-cell sequencing (abbreviated as tissue freezing solution), wherein the raw materials for preparing the tissue freezing solution for single-cell sequencing include sodium chloride (NaCl), sodium bicarbonate (NaHCO 3 ), potassium chloride (KCl), magnesium chloride hexahydrate (MgCl 2 6H 2 O), calcium chloride dihydrate (CaCl 2 ·2H 2 O), fetal bovine serum (FBS), dimethyl sulfoxide (DMSO), lactobionic acid, hydroxyethyl starch, adenosine, hemoglobin, mannitol, reduced glutathione, palmitoyl carnitine, carotenoids, ergothioneine and deionized water; the present invention does not specifically limit the sources of fetal bovine serum, lactobionic acid, hydroxyethyl starch, adenosine, hemoglobin, mannitol, reduced glutathione, palmitoyl carnitine, carotenoids, ergothioneine and the like, and directly purchased products can be used.

[0029] The tissue freezing solution provided by the present invention contains dimethyl sulfoxide, which is a cryoprotectant and also a permeability protectant, and can quickly penetrate the cell membrane into the cell, lower the freezing point of the cell, delay the freezing process, reduce the formation of ice crystals, and reduce the damage of free radicals to the cell, thereby reducing cell damage. The tissue freezing solution provided by the present invention contains lactobionic acid, hydroxyethyl starch and adenosine, which can provide energy and maintain the minimum physiological metabolic conditions of tissue cells. At the same time, hydroxyethyl starch and lactobionic acid can also be used as osmotic stabilizers to avoid cell membrane rupture caused by temperature changes under storage conditions or solution osmotic differences; the tissue freezing solution provided by the present invention contains hemoglobin, which can improve the stability and freezing effect of the tissue freezing solution; the tissue The freezing solution contains reduced glutathione, which can remove free radicals generated during tissue cell metabolism, maintain the redox environment in the cells, prevent cell apoptosis during storage, and prevent the resulting intracellular nucleic acid degradation; the tissue freezing solution provided by the present invention contains mannitol. The present invention finds that mannitol can not only reduce cell membrane rupture caused by osmotic pressure changes during freezing and thawing by regulating the osmotic pressure inside and outside the cells, but also remove free radicals generated during cell metabolism, reduce the damage of oxidative stress to cells, and help protect cell membranes and biological molecules in cells. In addition, mannitol can protect the structure and function of cells, especially under low-temperature storage conditions, it helps to stabilize cell membranes and organelles, thereby helping to improve cell survival rate.

[0030] The present invention finds that, although when the tissue cryopreservation solution simultaneously contains dimethyl sulfoxide, lactobionic acid, hydroxyethyl starch, adenosine, hemoglobin, mannitol and reduced glutathione, it has a good effect on enhancing the performance of the tissue cryopreservation solution in maintaining cell viability, reducing cell agglomeration rate and improving the nucleation rate, in particular, the tissue cryopreservation solution provided by the present invention also contains palmitoyl carnitine, carotenoids and ergothioneine, which is the first time that these three components are combined for use in tissue cryopreservation solution. The present invention finds that the combined use of palmitoyl carnitine, carotenoids and ergothioneine can further significantly enhance the performance of the tissue cryopreservation solution in maintaining cell viability, reducing cell agglomeration rate and improving the nucleation rate; this may be because the synergistic effect of these three components in the tissue cryopreservation solution, through a variety of mechanisms, jointly maintains the energy metabolism balance, antioxidant capacity and membrane stability of the cell, thereby significantly improving the cell viability, reducing the cell agglomeration rate and improving the nucleation rate. Specifically, the possible reason is that palmitoylcarnitine can promote the β-oxidation of fatty acids in mitochondria during the thawing process, help restore and maintain the energy supply of cells, support the function and repair ability of the nucleus, and ensure that more cells retain intact nuclei after thawing, which helps to improve cell viability, reduce cell agglomeration rate and increase the nucleus rate, which is crucial for cell cryopreservation; at the same time, palmitoylcarnitine has good antioxidant properties, which can reduce the damage of oxidative stress to cells, while carotenoids and ergothioneine can also indirectly support cell energy by reducing oxidative stress and protecting mitochondrial function. Metabolism, they jointly provide powerful antioxidant protection, reduce the accumulation of reactive oxygen species during freezing, protect cell membranes and organelles, thereby helping to maintain cell activity, protect the cell nucleus from damage, prevent cell apoptosis and nucleic acid degradation, reduce cell agglomeration rate and increase nucleation rate; in addition, palmitoylcarnitine and carotenoids work together to improve the fluidity and stability of cell membranes, reduce membrane rupture and cell-to-cell adhesion, help stabilize cell membranes, and reduce ice crystal damage to cells. At the same time, ergothioneine helps to reduce oxidative damage to cell membranes, reduce oxidative cross-linking of membrane proteins, and help reduce cell agglomeration rate.

[0031] The new tissue freezing solution provided by the present invention can effectively maintain cell activity, reduce cell loss during storage, reduce cell agglomeration rate, and is beneficial to improving the nucleation rate, thereby facilitating improving the sample quality and experimental reliability of single-cell sequencing; the tissue freezing solution for single-cell sequencing in the present invention can take into account the activity and function of multiple cell types, and is used to maintain the activity of different types of cells in the tissue, and can ensure that as many living cells as possible are obtained in the subsequent single-cell digestion and dissociation process.

[0032] According to some preferred embodiments, the raw materials for preparing the tissue cryopreservation solution for single-cell sequencing include the following components per 1000 parts by weight:

[0033] 3-5 parts of sodium chloride (e.g. 3, 3.5, 4, 4.5 or 5 parts), 0.5-1.5 parts of sodium bicarbonate (e.g. 0.5, 1 or 1.5 parts), 0.1-0.2 parts of potassium chloride (e.g. 0.1, 0.15 or 0.2 parts), 0.1-0.2 parts of magnesium chloride hexahydrate (e.g. 0.1, 0.15 or 0.2 parts), 0.1-0.2 parts of calcium chloride dihydrate (e.g. 0.1, 0.15 or 0.2 parts), 500mg of fetal bovine serum ~700 parts (e.g. 500, 550, 600, 650 or 700 parts), dimethyl sulfoxide 50~150 parts (e.g. 50, 60, 70, 80, 90, 100, 110, 120, 130, 140 or 150 parts), lactobionic acid 30~50 parts (e.g. 30, 35, 40, 45 or 50 parts), hydroxyethyl starch 30~60 parts (e.g. 30, 35, 40, 45, 50, 55 or 60 parts), Adenosine 0.5-2 parts (e.g. 0.5, 1, 1.5 or 2 parts), hemoglobin 1.8-4.2 parts (e.g. 1.8, 2, 2.2, 2.5, 2.8, 3, 3.3, 3.5, 3.8, 4 or 4.2 parts), mannitol 12-15 parts (e.g. 12, 13, 14 or 15 parts), reduced glutathione 1.2-1.8 parts (e.g. 1.2, 1.3, 1.4, 1.5, 1.6, 1.7 or 1.8 parts) ), 3 to 10 parts (e.g., 3, 4, 5, 6, 7, 8, 9 or 10 parts) of palmitoylcarnitine, 0.5 to 2 parts (e.g., 0.5, 1, 1.5 or 2 parts) of carotenoids, 1 to 5 parts (e.g., 1, 2, 3, 4 or 5 parts) of ergothioneine, and the balance deionized water; in the present invention, "parts" all refer to "parts by weight". In specific embodiments and comparative examples, the units of parts by weight can be unified as weight units such as "g" or "kg".

[0034] According to some preferred embodiments, the mass ratio of the palmitoylcarnitine, the carotenoid and the ergothioneine is (4-6):1:(1.8-2.5); after a large number of experiments, the present invention has determined that the optimal mass ratio of palmitoylcarnitine, carotenoid and ergothioneine when used in combination in a tissue freezing solution is (4-6):1:(1.8-2.5). This ideal mass ratio enables the tissue freezing solution to achieve optimal performance in terms of improving cell viability, reducing cell agglomeration rate and increasing nucleation rate.

[0035] According to some preferred embodiments, the carotenoids are one or more of β-carotene, astaxanthin, and lycopene. The present invention does not specifically limit the sources of β-carotene, astaxanthin, lycopene, etc., and directly purchasable products may be used.

[0036] According to some preferred embodiments, the pH value of the tissue freezing solution used for single-cell sequencing is 7.3-7.6 (eg, 7.3, 7.4, 7.5 or 7.6).

[0037] According to some preferred embodiments, hydrochloric acid solution and / or sodium hydroxide solution are used to adjust the pH value of the tissue freezing solution for single-cell sequencing to 7.3-7.6; the present invention does not specifically limit the concentration and dosage of the hydrochloric acid solution and the sodium hydroxide solution, and it is sufficient to adjust the pH value of the tissue freezing solution for single-cell sequencing to within the target range, which can be routinely selected by those skilled in the art.

[0038] In a second aspect, the present invention provides a method for preparing a tissue cryopreservation solution for single-cell sequencing according to the first aspect of the present invention, the method comprising the following steps:

[0039] (1) Weighing each raw material and mixing and stirring to disperse uniformly to obtain a freezing solution system; in the present invention, the speed of the stirring and dispersing can be, for example, 400-800 r / min, and the time of the stirring and dispersing can be, for example, 2-6 h; in the present invention, in order to make the dispersion uniformity of the freezing solution system better, it is preferred that a portion of dimethyl sulfoxide is first used to uniformly disperse palmitoyl carnitine and carotenoids, and then added to the mixed system formed by other raw materials and continued to stir and disperse to obtain the freezing solution system; the amount of dimethyl sulfoxide used to uniformly disperse palmitoyl carnitine and carotenoids is, for example, 30-50% of the total mass of dimethyl sulfoxide;

[0040] (2) The cryopreservation solution system is sterilized by filtering to prepare tissue cryopreservation solution for single-cell sequencing.

[0041] According to some preferred embodiments, before the freezing solution system is filtered and sterilized, the pH of the freezing solution system is adjusted to 7.3-7.6.

[0042] According to some preferred embodiments, the filter is a filter with a pore size of 0.22 μm; and / or the tissue cryopreservation solution for single-cell sequencing is stored at -20°C.

[0043] The third aspect of the present invention provides an application of the tissue cryopreservation solution for single-cell sequencing described in the first aspect of the present invention in single-cell sequencing; the present invention prepares a simple, safe and effective tissue cryopreservation solution, which can effectively maintain the activity of in vitro tissue cells and can be widely used in related scientific research experiments such as high-throughput single-cell sequencing; in the present invention, the single-cell sequencing refers to the technology of sequencing and analyzing the genome, transcriptome and epigenome levels at the single cell level.

[0044] According to some preferred embodiments, the application is: first, the tissue is frozen using the tissue freezing solution for single-cell sequencing, then the frozen tissue is revived and digested into a single-cell suspension, and finally the single-cell suspension is used for single-cell sequencing; in the present invention, the operations of freezing the tissue, reviving the frozen tissue, and digesting the tissue into a single-cell suspension are routine techniques in the art and can be routinely selected by those skilled in the art.

[0045] According to some specific embodiments, the single cell suspension is prepared as follows:

[0046] S1. Tissue cryopreservation: The spleen, liver, kidney and intestinal tissues of mice are preserved (cryopreserved) using the tissue cryopreservation solution of the present invention, comprising the following sub-steps:

[0047] S11. Before use, completely thaw and mix the tissue freezing solution;

[0048] S12, cutting about 200 mg of tissue (soybean size) from fresh ex vivo tissue;

[0049] S13, washing the obtained fresh ex vivo tissue with PBS buffer (pH=7.4) to remove the blood in the tissue; the concentration of the PBS buffer may be, for example, 0.01-0.1 mol / L;

[0050] S14, cutting the washed tissue sample into a size of 1 mm (length) × 1 mm (width) × 1 mm (height);

[0051] S15. Calculate the volume of tissue freezing solution to be added based on the weight of the tissue. Generally, the volume of tissue freezing solution is 10 times the weight of the tissue. For example, 100 mg of tissue sample corresponds to 1 mL of tissue freezing solution. Use a pipette to draw up the tissue freezing solution and gently blow to resuspend the tissue.

[0052] S16, packing the above tissues into tissue cryopreservation tubes according to volume and marking them;

[0053] S17. Place the tissue cryopreservation tube in a device that can gradually lower the temperature, such as a programmed freezing box, and then place it in a -80℃ refrigerator, ensuring that the temperature drops at a rate of approximately 1℃ / min.

[0054] S2. Tissue resuscitation: The frozen tissues were resuscitated after one week and one month (30 days) of cryopreservation. Tissue resuscitation includes the following sub-steps:

[0055] S21, open a constant temperature water bath, set it to 37°C, take a centrifuge tube, add 5 mL of cell culture medium, and incubate in a 37°C water bath until the temperature of the culture medium reaches 37°C, and the incubation time is about 2 to 5 min; in the present invention, the cell culture medium can be selected from one or more of MEM culture medium, DMEM culture medium, RPMI 1640 culture medium, and IMDM culture medium;

[0056] S22, take out the tissue cryopreservation tube, immediately put it into a water bath and shake it quickly to melt the tissue cryopreservation solution quickly;

[0057] S23. After complete thawing, immediately clean the outside of the tissue cryopreservation tube with an alcohol cotton ball to reduce the probability of contamination;

[0058] S24, immediately open the tissue cryopreservation tube, add the tissue cryopreservation solution drop by drop into the above-mentioned incubated culture medium, shake while adding, and put it into the centrifuge after the completion, 4℃, 300×g, centrifuge for 5 minutes;

[0059] S25. Discard the supernatant and complete tissue recovery.

[0060] S3. Digest tissue into single-cell suspension: Use a tissue dissociation kit to digest the resuscitated tissue into a single-cell suspension, which can be used for experiments such as single-cell sequencing. The present invention does not make any specific limitation on the tissue dissociation kit, and products that can be directly purchased can be used. Those skilled in the art can select a corresponding applicable tissue dissociation kit according to the different routines of the tissue. The present invention does not make any specific limitation on the operation of using a tissue dissociation kit to digest the resuscitated tissue into a single-cell suspension, which is a conventional technique in the art.

[0061] The present invention will be further described below by way of examples, but the protection scope of the present invention is not limited to these embodiments. The present invention may also have other various embodiments, and those skilled in the art may make various corresponding changes and deformations according to the present invention without departing from the spirit and essence of the present invention, but these corresponding changes and deformations shall all belong to the protection scope of the claims attached to the present invention.

[0062] Example 1

[0063] A tissue cryopreservation solution for single-cell sequencing, wherein the raw materials for preparing the tissue cryopreservation solution for single-cell sequencing include the following components per 1000 g of the raw materials:

[0064] 4 g of sodium chloride, 1 g of sodium bicarbonate, 0.15 g of potassium chloride, 0.15 g of magnesium chloride hexahydrate, 0.15 g of calcium chloride dihydrate, 500 g of fetal bovine serum, 100 g of dimethyl sulfoxide, 40 g of lactobionic acid, 50 g of hydroxyethyl starch, 1.5 g of adenosine, 3 g of hemoglobin, 14 g of mannitol, 1.5 g of reduced glutathione, 5 g of palmitoylcarnitine, 1 g of carotenoid (β-carotene), 2 g of ergothioneine and 276.55 g of deionized water. The pH of the tissue freezing solution for single-cell sequencing is 7.4. The formula is shown in Table 1 below.

[0065] Table 1: Tissue freezing solution formula

[0066]

[0067] like Figure 1 As shown, the method for preparing the tissue freezing solution for single-cell sequencing includes:

[0068] ① Weigh each raw material according to the amount in Table 1.

[0069] ② First, add 5g of palmitoylcarnitine and 1g of carotenoids to 50g of dimethyl sulfoxide and stir and disperse at 500r / min for 3h to obtain a uniformly dispersed dispersion; then add the other raw materials to deionized water to obtain a mixed system, and then add the dispersion to the mixed system and stir and disperse at 500r / min for 3h to obtain a uniformly dispersed freezing solution system.

[0070] ③ Adjust the pH of the freezing solution system to 7.4, and then filter and sterilize using a filter with a pore size of 0.22 μm to obtain the tissue freezing solution for single-cell sequencing (abbreviated as tissue freezing solution), which is stored at -20°C.

[0071] Example 2

[0072] Embodiment 2 is substantially the same as Embodiment 1, except that:

[0073] In this example, raw materials for preparing tissue cryopreservation solution for single-cell sequencing are prepared, and each 1000 g of raw materials contains the following components:

[0074] 4 g of sodium chloride, 1 g of sodium bicarbonate, 0.15 g of potassium chloride, 0.15 g of magnesium chloride hexahydrate, 0.15 g of calcium chloride dihydrate, 500 g of fetal bovine serum, 100 g of dimethyl sulfoxide, 40 g of lactobionic acid, 50 g of hydroxyethyl starch, 1.5 g of adenosine, 3 g of hemoglobin, 14 g of mannitol, 1.5 g of reduced glutathione, 3 g of palmitoylcarnitine, 2 g of carotenoid (β-carotene), 5 g of ergothioneine and 274.55 g of deionized water, wherein the pH of the tissue freezing solution for single-cell sequencing is 7.4.

[0075] The method for preparing tissue cryopreservation solution for single-cell sequencing in this example is basically the same as that in Example 1, except that:

[0076] ② First, add 3g palmitoylcarnitine and 2g carotenoid (β-carotene) to 50g dimethyl sulfoxide and stir and disperse at 500r / min for 3h to obtain a uniformly dispersed dispersion; then add other raw materials to deionized water to obtain a mixed system, and then add the dispersion to the mixed system and stir and disperse at 500r / min for 3h to obtain a uniformly dispersed freezing solution system.

[0077] Example 3

[0078] Embodiment 3 is substantially the same as Embodiment 1, except that:

[0079] In this example, raw materials for preparing tissue cryopreservation solution for single-cell sequencing are prepared, and each 1000 g of raw materials contains the following components:

[0080] 4 g of sodium chloride, 1 g of sodium bicarbonate, 0.15 g of potassium chloride, 0.15 g of magnesium chloride hexahydrate, 0.15 g of calcium chloride dihydrate, 500 g of fetal bovine serum, 100 g of dimethyl sulfoxide, 40 g of lactobionic acid, 50 g of hydroxyethyl starch, 1.5 g of adenosine, 3 g of hemoglobin, 14 g of mannitol, 1.5 g of reduced glutathione, 10 g of palmitoylcarnitine, 0.5 g of carotenoid (β-carotene), 1 g of ergothioneine and 273.05 g of deionized water, wherein the pH of the tissue freezing solution for single-cell sequencing is 7.4.

[0081] The method for preparing tissue cryopreservation solution for single-cell sequencing in this example is basically the same as that in Example 1, except that:

[0082] ② First, add 10g palmitoylcarnitine and 0.5g carotenoid (β-carotene) into 50g dimethyl sulfoxide and stir and disperse at 500r / min for 3h to obtain a uniformly dispersed dispersion; then add other raw materials into deionized water to obtain a mixed system, and then add the dispersion into the mixed system and stir and disperse at 500r / min for 3h to obtain a uniformly dispersed freezing solution system.

[0083] Comparative Example 1

[0084] Comparative Example 1 is substantially the same as Example 1, except that:

[0085] In this comparative example, raw materials for preparing tissue cryopreservation solution for single-cell sequencing are prepared, and each 1000 g of raw materials contains the following components:

[0086] 4 g of sodium chloride, 1 g of sodium bicarbonate, 0.15 g of potassium chloride, 0.15 g of magnesium chloride hexahydrate, 0.15 g of calcium chloride dihydrate, 500 g of fetal bovine serum, 100 g of dimethyl sulfoxide, 40 g of lactobionic acid, 50 g of hydroxyethyl starch, 1.5 g of adenosine, 3 g of hemoglobin, 14 g of mannitol, 1.5 g of reduced glutathione, 1 g of carotenoid (β-carotene), 2 g of ergothioneine and 281.55 g of deionized water, wherein the pH of the tissue freezing solution for single-cell sequencing is 7.4.

[0087] The method for preparing the tissue cryopreservation solution for single-cell sequencing in this comparative example is basically the same as that in Example 1, except that:

[0088] ② First, add 1g of carotenoid (β-carotene) to 50g of dimethyl sulfoxide and stir and disperse at 500r / min for 3h to obtain a uniformly dispersed dispersion; then add other raw materials to deionized water to obtain a mixed system, and then add the dispersion to the mixed system and stir and disperse at 500r / min for 3h to obtain a uniformly dispersed freezing solution system.

[0089] Comparative Example 2

[0090] Comparative Example 2 is substantially the same as Example 1, except that:

[0091] In this example, the raw materials for preparing the tissue cryopreservation solution for single-cell sequencing include the following components per 1000 g of raw materials:

[0092] 4 g of sodium chloride, 1 g of sodium bicarbonate, 0.15 g of potassium chloride, 0.15 g of magnesium chloride hexahydrate, 0.15 g of calcium chloride dihydrate, 500 g of fetal bovine serum, 100 g of dimethyl sulfoxide, 40 g of lactobionic acid, 50 g of hydroxyethyl starch, 1.5 g of adenosine, 3 g of hemoglobin, 14 g of mannitol, 1.5 g of reduced glutathione, 5 g of palmitoylcarnitine, 2 g of ergothioneine and 277.55 g of deionized water, wherein the pH of the tissue freezing solution for single-cell sequencing is 7.4.

[0093] The method for preparing the tissue cryopreservation solution for single-cell sequencing in this comparative example is basically the same as that in Example 1, except that:

[0094] ② First, add 5g of palmitoylcarnitine to 50g of dimethyl sulfoxide and stir and disperse at 500r / min for 3h to obtain a uniformly dispersed dispersion; then add the other raw materials to deionized water to obtain a mixed system, and then add the dispersion to the mixed system and stir and disperse at 500r / min for 3h to obtain a uniformly dispersed freezing solution system.

[0095] Comparative Example 3

[0096] Comparative Example 3 is substantially the same as Example 1, except that:

[0097] In this comparative example, raw materials for preparing tissue cryopreservation solution for single-cell sequencing are prepared, and each 1000 g of raw materials contains the following components:

[0098] 4 g of sodium chloride, 1 g of sodium bicarbonate, 0.15 g of potassium chloride, 0.15 g of magnesium chloride hexahydrate, 0.15 g of calcium chloride dihydrate, 500 g of fetal bovine serum, 100 g of dimethyl sulfoxide, 40 g of lactobionic acid, 50 g of hydroxyethyl starch, 1.5 g of adenosine, 3 g of hemoglobin, 14 g of mannitol, 1.5 g of reduced glutathione, 5 g of palmitoyl carnitine, 1 g of carotenoid (β-carotene) and 278.55 g of deionized water, wherein the pH of the tissue freezing solution for single-cell sequencing is 7.4.

[0099] Comparative Example 4

[0100] Comparative Example 4 is substantially the same as Example 1, except that:

[0101] In this comparative example, raw materials for preparing tissue cryopreservation solution for single-cell sequencing are prepared, and each 1000 g of raw materials contains the following components:

[0102] 4 g of sodium chloride, 1 g of sodium bicarbonate, 0.15 g of potassium chloride, 0.15 g of magnesium chloride hexahydrate, 0.15 g of calcium chloride dihydrate, 500 g of fetal bovine serum, 100 g of dimethyl sulfoxide, 40 g of lactobionic acid, 50 g of hydroxyethyl starch, 1.5 g of adenosine, 3 g of hemoglobin, 14 g of mannitol, 1.5 g of reduced glutathione and 284.55 g of deionized water, wherein the pH of the tissue freezing solution for single-cell sequencing is 7.4.

[0103] The method for preparing the tissue cryopreservation solution for single-cell sequencing in this comparative example is basically the same as that in Example 1, except that:

[0104] ② Add all raw materials into deionized water to obtain a mixed system and stir and disperse at 500r / min for 3h to obtain a uniformly dispersed freezing solution system.

[0105] Comparative Example 5

[0106] Comparative Example 5 is substantially the same as Example 1, except that:

[0107] In this comparative example, raw materials for preparing tissue cryopreservation solution for single-cell sequencing are prepared, and each 1000 g of raw materials contains the following components:

[0108] 4 g of sodium chloride, 1 g of sodium bicarbonate, 0.15 g of potassium chloride, 0.15 g of magnesium chloride hexahydrate, 0.15 g of calcium chloride dihydrate, 500 g of fetal bovine serum, 100 g of dimethyl sulfoxide, 40 g of lactobionic acid, 50 g of hydroxyethyl starch, 1.5 g of adenosine, 1.5 g of reduced glutathione, 5 g of palmitoylcarnitine, 1 g of carotenoid (β-carotene), 2 g of ergothioneine and 293.55 g of deionized water, wherein the pH of the tissue freezing solution for single-cell sequencing is 7.4.

[0109] Comparative Example 6

[0110] This comparative example provides a commonly used tissue freezing solution. Each 1000 mL of the tissue freezing solution contains 800 mL of RPMI 1640 culture medium, 100 mL of fetal bovine serum FBS, and 100 mL of dimethyl sulfoxide DMSO. The tissue freezing solution is prepared by mixing the three components thoroughly and then storing them at -20°C.

[0111] The present invention uses the tissue freezing solution in each embodiment and each comparative example to freeze the mouse spleen tissue, then revive the frozen tissue and digest the tissue into a single cell suspension, and then evaluates the quality of the single cell suspension by AO / PI staining to measure the freezing (preservation) effect of the tissue freezing solution. The results are shown in Table 2. The present invention measures that the cell viability of the single cell suspension made from fresh mouse spleen tissue is 97.43%, the cell agglomeration rate is 1.52%, and the nucleation rate is 92%.

[0112] In the present invention, the single cell suspension is prepared as follows:

[0113] S1. Tissue cryopreservation: Preserving (cryopreserving) mouse tissue with tissue cryopreservation solution, including the following sub-steps:

[0114] S11. Before use, completely thaw and mix the tissue freezing solution;

[0115] S12, cutting about 200 mg of tissue (soybean size) from fresh ex vivo tissue;

[0116] S13, washing the obtained fresh ex vivo tissue with PBS buffer (pH=7.4) to remove the blood in the tissue; the concentration of the PBS buffer is 0.1 mol / L;

[0117] S14, cutting the washed tissue sample into a size of 1 mm (length) × 1 mm (width) × 1 mm (height);

[0118] S15. Calculate the volume of tissue freezing solution to be added based on the weight of the tissue. For every 100 mg of tissue sample, add 1 mL of tissue freezing solution. Use a pipette to draw up the tissue freezing solution and gently pipette to resuspend the tissue.

[0119] S16, packing the above tissues into tissue cryopreservation tubes according to volume and marking them;

[0120] S17. Place the tissue cryopreservation tube in a device that can gradually lower the temperature, in a programmed freezing box, and then put it in a -80℃ refrigerator, ensuring that the temperature drops at a rate of 1℃ / min.

[0121] S2. Tissue resuscitation: The frozen tissues were resuscitated after one week and one month (30 days) of cryopreservation. Tissue resuscitation includes the following sub-steps:

[0122] S21. Turn on the constant temperature water bath and set it to 37°C. Take a centrifuge tube and add 5 mL of cell culture medium (RPMI 1640 culture medium). Incubate in a 37°C water bath until the temperature of the culture medium reaches 37°C. The incubation time is 5 min.

[0123] S22, take out the tissue cryopreservation tube, immediately put it into a water bath and shake it quickly to melt the tissue cryopreservation solution quickly;

[0124] S23. After complete thawing, immediately clean the outside of the tissue cryopreservation tube with an alcohol cotton ball to reduce the probability of contamination;

[0125] S24, immediately open the tissue cryopreservation tube, add the tissue cryopreservation solution drop by drop into the above-mentioned incubated culture medium, shake while adding, and put it into the centrifuge after the completion, 4℃, 300×g, centrifuge for 5 minutes;

[0126] S25. Discard the supernatant and complete tissue recovery.

[0127] S3. Tissue digestion into single-cell suspension: Use the corresponding tissue dissociation kit to digest the resuscitated tissue into a single-cell suspension.

[0128] Table 2: Quality test results of mouse spleen tissue preserved in tissue cryopreservation solution

[0129]

[0130] The present invention also provides the tissue cryopreservation solution in Example 1 and the tissue cryopreservation solution in Comparative Example 6. The same mouse spleen tissue is preserved for one month (30 days) and then revived. The live cell fluorescence images in the single cell suspension of the mouse spleen tissue preserved by the two tissue cryopreservation solutions are measured by AO / PI staining method. Figure 2 shown.

[0131] The present invention also uses the tissue freezing solution in Example 1, Comparative Example 4 and Comparative Example 6 to freeze mouse intestinal tissue, mouse kidney tissue and mouse liver tissue, respectively, and then revive the frozen tissue and digest the tissue into a single cell suspension, and then evaluate the quality of the single cell suspension by AO / PI staining to measure the freezing (preservation) effect of the tissue freezing solution, and the results are shown in Table 3, Table 4 and Table 5, respectively; the present invention measures that the cell viability of the single cell suspension made from fresh mouse intestinal tissue is 93.47%, the cell agglomeration rate is 8.28%, and the nucleation rate is 95%, the cell viability of the single cell suspension made from fresh mouse kidney tissue is 96.14%, the cell agglomeration rate is 3.67%, and the nucleation rate is 82%, and the cell viability of the single cell suspension made from fresh mouse liver tissue is 96.85%, the cell agglomeration rate is 1.54%, and the nucleation rate is 96%.

[0132] Table 3: Quality test results of mouse intestinal tissue preserved in tissue cryopreservation solution

[0133]

[0134] Table 4: Quality test results of mouse kidney tissue preserved in tissue cryopreservation solution

[0135]

[0136] Table 5: Quality test results of mouse liver tissue preserved in tissue cryopreservation solution

[0137]

[0138] It can be seen from the results of Tables 2 to 5 that after freezing mouse tissue for one week and one month (30 days), the tissue cryopreservation solution for single-cell sequencing in the preferred embodiment of the present invention has basically no decrease in cell viability, a slight increase in cell agglomeration rate, and basically no decrease in nucleation rate compared to fresh mouse tissue, thus maintaining very high cell activity and being particularly suitable for subsequent single-cell sequencing requirements.

[0139] The present invention also uses the tissue cryopreservation solution in Example 1 for human clinical tissue cryopreservation. Fresh human clinical colorectal cancer tissue and liver cancer tissue surgical samples are processed into tissue blocks of 1 mm (length) × 1 mm (width) × 1 mm (height), respectively, and cryopreserved in 1.5 mL of tissue cryopreservation solution at -20°C. After 30 days, the tissues are taken out for digestion and dissociation to obtain single cell suspensions, which are then stained with AO / PI. The fluorescence images of live cells in the single cell suspensions of colorectal cancer tissue and liver cancer tissue are respectively as shown in FIG. Figure 3 Shown and Figure 4As shown; and the AO / PI staining method measured that the cell viability of the human clinical tissue after being frozen in the tissue freezing solution in this Example 1 for one week and one month (30 days) was not less than 90%, indicating that the tissue freezing solution in the present invention can maintain very good cell activity for 30 days when freezing human clinical tissue samples.

[0140] The parts of the present invention that are not described in detail are well-known technologies to those skilled in the art, and those skilled in the art can make selections as needed.

[0141] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although detailed descriptions have been made with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.

Claims

1. A tissue cryopreservation solution for single-cell sequencing, Features: The raw materials for preparing the tissue freezing solution for single-cell sequencing include the following components per 1000 parts by weight: 3-5 parts of sodium chloride, 0.5-1.5 parts of sodium bicarbonate, 0.1-0.2 parts of potassium chloride, 0.1-0.2 parts of magnesium chloride hexahydrate, 0.1-0.2 parts of calcium chloride dihydrate, 500-700 parts of fetal bovine serum, 50-150 parts of dimethyl sulfoxide, 30-50 parts of lactobionic acid, 30-60 parts of hydroxyethyl starch, 0.5-2 parts of adenosine, 1.8-4.2 parts of hemoglobin, 12-15 parts of mannitol, 1.2-1.8 parts of reduced glutathione, 3-10 parts of palmitoyl carnitine, 0.5-2 parts of carotenoids, 1-5 parts of ergothioneine, and the balance of deionized water; The mass ratio of the palmitoylcarnitine, the carotenoid and the ergothioneine is (4-6):1:(1.8-2.5).

2. The tissue freezing solution for single-cell sequencing according to claim 1, Features: The carotenoids are one or more of β-carotene, astaxanthin and lycopene.

3. The tissue freezing solution for single-cell sequencing according to claim 1, Features: The pH value of the tissue freezing solution used for single-cell sequencing is 7.3-7.

6.

4. The tissue freezing solution for single-cell sequencing according to claim 3, Features: The pH value of the tissue freezing solution for single-cell sequencing is adjusted to 7.3-7.6 using hydrochloric acid solution and / or sodium hydroxide solution.

5. The method for preparing a tissue freezing solution for single-cell sequencing according to any one of claims 1 to 4, It is characterized in that The method comprises the following steps: (1) Weighing each raw material and mixing and stirring to uniformly disperse it to obtain a freezing solution system; (2) The cryopreservation solution system is sterilized by filtering to prepare tissue cryopreservation solution for single-cell sequencing.

6. The preparation method according to claim 5, Features: Before filtering and sterilizing the freezing solution system, the pH of the freezing solution system is adjusted to 7.3-7.

6.

7. The preparation method according to claim 5, Features: The filter is a filter with a pore size of 0.22 μm; and / or The tissue freezing solution for single-cell sequencing was stored at -20°C.

8. Use of the tissue freezing solution for single-cell sequencing according to any one of claims 1 to 4 in single-cell sequencing.

9. The use according to claim 8, Features: The application is: firstly cryopreserving the tissue using the tissue cryopreservation solution for single-cell sequencing, then reviving the frozen tissue and digesting the tissue into a single-cell suspension, and finally performing single-cell sequencing using the single-cell suspension.